51824 Federal Register / Vol. 70, No. 168 / Wednesday, August 31, 2005 / Notices 

trends over many selections within a 

given occupational or organizational 

area. The information is treated in a 

confidential manner. No information 

from the form is entered into the official 

personnel file of the individual selected 

and all forms are destroyed after the 

conclusion of the selection process. The 

format of the questions on ethnicity and 

race are compliant with OMB 

requirements and comparable to those 

used by other agencies. 

The FTC staff estimates that up to 

5,000 applicants will submit the form as 

part of the new online application 

process and that the form will require 5 

minutes to complete, for an annual 

burden total of approximately 400 

hours. 

Annual cost burden: 

The cost per respondent should be 

negligible. Participation is voluntary 

and will not require any labor 

expenditures by respondents. There are 

no capital, start-up, operation, 

maintenance, or other similar costs to 

the respondents. 

Christian S. White, 

Acting General Counsel. 

[FR Doc. 05–17326 Filed 8–30–05; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Committee on Vital and Health 

Statistics: Meeting 

Pursuant to the Federal Advisory 

Committee Act, the Department of 

Health and Human Services (HHS) 

announces the following advisory 

committee meeting. 

Name: National Committee on Vital and 

Health Statistics (NCVHS), Subcommittee on 

Standards and Security (SSS). 

Time and Date: September 21, 2005: 9 

a.m.–5 p.m.; September 22, 2005: 8:30 a.m.–

12 p.m. 

Place: Hubert H. Humphrey Building, 200 

Independence Avenue SW., Room 705A, 

Washington, DC 20201. 

Status: Open. 

Purpose: On the first day the 

Subcommittee will focus on two topics: 

introductory discussions of the issues 

surrounding matching patients with their 

records, and then continued explorations 

into issues around HIPAA Return on 

Investment (ROI). The second day open with 

an overview of the e-prescribing pilots 

required under Medicare Modernization Act 

(MMA) and will move to continued 

discussions on the secondary use of clinical 

data. 

Contact Person for More Information: 

Substantive program information as well as 

summaries of meetings and a roster of 

Committee members may be obtained from 

Maria Friedman, Health Insurance Specialist, 

Security and Standards Group, Centers for 

Medicare and Medicaid Services, MS: C5–

24–04, 7500 Security Boulevard, Baltimore, 

MD 21244–1850, telephone: 410–786–6333 

or Marjorie S. Greenberg, Executive 

Secretary, NCVHS, National Center for 

Health Statistics, Centers for Disease Control 

and Prevention, Room 1100, Presidential 

Building, 3311 Toledo Road, Hyattsville, 

Maryland 20782, telephone: (301) 458–4245. 

Information also is available on the NCVHS 

home page of the HHS Web site: http:// 

www.nevhs.hhs.gov/ where an agenda for the 

meeting will be posted when available. 

Should you require reasonable 

accommodation, please contact the CDC 

Office of Equal Employment Opportunity on 

(301) 458–3EEO (4336) as soon as possible. 

Dated: August 23, 2005. 

James Scanlon, 

Acting Deputy Assistant Secretary for Science 

and Data Policy, Office of the Assistant 

Secretary for Planning and Evaluation. 

[FR Doc. 05–17345 Filed 8–30–05; 8:45 am] 

BILLING CODE 4151–05–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Meeting 

National Center for Health Statistics 

(NCHS), Classifications and Public 

Health Data Standards announces the 

following meeting. 

Name: ICD–9–CM Coordination and 

Maintenance Committee meeting. 

Times and Dates: 9 a.m.–4 p.m., September 

29, 2005. 9 a.m.–4 p.m., September 30, 2005. 

Place: Centers for Medicare and Medicaid 

Services (CMS) Auditorium, 7500 Security 

Boulevard, Baltimore, Maryland. 

Status: Open to the public. 

Purpose: The ICD–9–CM Coordination and 

Maintenance (C&M) Committee will hold its 

final meeting of the 2005 calendar year cycle 

on Thursday and Friday, September 29–30, 

2005. The C&M meeting is a public forum for 

the presentation of proposed modifications to 

the International Classification of Diseases, 

Ninth-Revision, and Clinical Modification. 

Matters to be Discussed: Agenda items 

include: Complex and simple febrile 

seizures, family history of colonic polyps, 

mucositis, newborn post discharge check, 

benign prostatic hypertrophy with lower 

urinary tract symptoms, acute and chronic 

gingival disease, anal sphincter tear, addenda 

(diagnosis), cervical stump prolapse, growthguidance device/8-plate, M-brace dynamic 

spinal stabilization system, implantable 

hemodynamic monitor, injection or infusion 

of Levosimendan, laparoscopic hysterectomy, 

Taylor spatial frame, bifurcated vessel 

procedure, EPS studies, addenda 

(procedures), ICD–10–Procedure Coding 

System (PCS) update. 

For Further Information Contact: Amy 

Blum, Medical Systems Specialist, 

Classifications and Public Health Data 

Standards Staff, NCHS, 3311 Toledo Road, 

Room 2402, Hyattsville, Maryland 20782, email alb8@cdc.gov, telephone 301–458–4106 

(diagnosis), Mady Hue, Health Insurance 

Specialist, Division of Acute Care, CMS, 7500 

Security Blvd., Baltimore, Maryland 21244, 

e-mail Marilu.Hue@cms.hhs.gov, telephone 

410–786–4510 (procedures). 

Notice: Because of increased security 

requirements, CMS has instituted stringent 

procedures for entrance into the building by 

non-government employees. Persons without 

a government I.D. will need to show an 

official form of picture I.D., (such as a 

driver’s license), and sign-in at the security 

desk upon entering the building. Those who 

wish to attend a specific ICD–9–CM C&M 

meeting in the CMS auditorium must submit 

their name and organization for addition to 

the meeting visitor list. Those wishing to 

attend the September 29–30, 2005 meeting 

must submit their name and organization by 

September 26, 2005 for inclusion on the 

visitor list. This visitor list will be 

maintained at the front desk of the CMS 

building and used by the guards to admit 

visitors to the meeting. Those who attended 

previous ICD–9–CM C&M meetings will no 

longer be automatically added to the visitor 

list. You must request inclusion of your name 

prior to each meeting you attend. Register to 

attend the meeting on-line at: http:// 

cms.hhs.gov/events. 

Notice: This is a public meeting. However, 

because of fire code requirements, should the 

number of attendants meet the capacity of the 

room, the meeting will be closed. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: August 24, 2005. 

B. Kathy Skipper, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 05–17325 Filed 8–30–05; 8:45 am] 

BILLING CODE 4163–18–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Environmental 

Health/Agency for Toxic Substances 

and Disease Registry 

The Community and Tribal 

Subcommittee of the Board of Scientific 

Counselors (BSC), Centers for Disease 

Control and Prevention (CDC), National 

Center for Environmental Health/ 

Agency for Toxic Substances and 

Disease Registry (NCEH/ATSDR): 

Teleconference. 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

Federal Register / Vol. 70, No. 168 / Wednesday, August 31, 2005 / Notices 51825 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention, NCEH/ATSDR 

announces the following subcommittee 

meeting: 

Name: Community and Tribal 

Subcommittee (CTS). 

Time and Date: 3 p.m.–4:30 p.m., 

September 8, 2005. 

Place: The teleconference will originate at 

the National Center for Environmental 

Health/Agency for Toxic Substances and 

Disease Registry in Atlanta, Georgia. Please 

see Supplementary Information for details on 

accessing the teleconference. 

Status: Open to the public, teleconference 

access limited only by availability of 

telephone ports. 

Purpose: Under the charge of the Board of 

Scientific Counselors, NCEH/ATSDR the 

Community and Tribal Subcommittee will 

provide the BSC, NCEH/ATSDR with a forum 

for community and tribal first-hand 

perspectives on the interactions and impacts 

of the NCEH/ATSDR’s national and regional 

policies, practices and programs. 

Matters To Be Discussed: The 

teleconference agenda will include an update 

on the Report on the Program Peer Review 

Subcommittee, a discussion on the NCEH/ 

ATSDR portfolio of programs; and an open 

discussion for other important issues. 

Items are subject to change as priorities 

dictate. 

Supplementary Information: This 

conference call is scheduled to begin at 3 

p.m. eastern standard time. To participate in 

the teleconference, please dial (877) 315–

6535 and enter conference code 383520. 

For Further Information Contact: Sandra 

Malcom, Committee Management Specialist, 

Office of Science, NCEH/ATSDR, M/S E–28, 

1600 Clifton Road, NE., Atlanta, Georgia 

30333, telephone (404) 498–0003. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and the National Center for 

Environmental Health/Agency for Toxic 

Substances and Disease Registry. 

Dated: August 25, 2005. 

B. Kathy Skipper, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 05–17295 Filed 8–30–05; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Agency for Toxic Substances and 

Disease Registry (ATSDR) Public 

Meeting of the Citizens Advisory 

Committee on Public Health Service 

(PHS) Activities and Research at 

Department of Energy (DOE) Sites: 

Oak Ridge Reservation Health Effects 

Subcommittee 

Name: Public meeting of the Citizens 

Advisory Committee on PHS Activities and 

Research at DOE Sites: Oak Ridge 

Reservation Health Effects Subcommittee 

(ORRHES). 

Time and Date: 12 p.m.—8 p.m., 

September 22, 2005. 

Place: Oak Ridge Mall, Alpine Room, 333 

East Main Street, Oak Ridge, Tennessee 

37830. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 50 people. 

Background: A Memorandum of 

Understanding (MOU) was signed in October 

1990 and renewed in September 2000 

between ATSDR and DOE. The MOU 

delineates the responsibilities and 

procedures for ATSDR’s public health 

activities at DOE sites required under 

sections 104, 105, 107, and 120 of the 

Comprehensive Environmental Response, 

Compensation, and Liability Act (CERCLA or 

‘‘Superfund’’). These activities include health 

consultations and public health assessments 

at DOE sites listed on, or proposed for, the 

Superfund National Priorities List and at 

sites that are the subject of petitions from the 

public; and other health-related activities 

such as epidemiologic studies, health 

surveillance, exposure and disease registries, 

health education, substance-specific applied 

research, emergency response, and 

preparation of toxicological profiles. In 

addition, under an MOU signed in December 

1990 with DOE and replaced by an MOU 

signed in 2000, the Department of Health and 

Human Services (DHHS) has been given the 

responsibility and resources for conducting 

analytic epidemiologic investigations of 

residents of communities in the vicinity of 

DOE facilities, workers at DOE facilities, and 

other persons potentially exposed to 

radiation or to potential hazards from nonnuclear energy production and use. DHHS 

has delegated program responsibility to CDC. 

Community involvement is a critical part of 

ATSDR’s and CDC’s energy-related research 

and activities, and input from members of the 

ORRHES is part of these efforts. 

Purpose: The purpose of this meeting is to 

address issues that are unique to community 

involvement with the ORRHES, and agency 

updates. 

Matters To Be Discussed: Agenda items 

will include a brief discussion on the Beir VII 

report; a presentation on the draft public 

health assessment: Current and Future 

Chemical Exposure Evaluation (1990–2003); 

an update on ATSDR’s project management 

plan and the schedule of public health 

assessments to be released in FY2005–2006; 

updates and recommendations from the 

Exposure Evaluation, Community Concerns 

and Communications, and the Health 

Outcome Data Workgroups; and agency 

updates. 

Agenda items are subject to change as 

priorities dictate. 

For Further Information Contact: Marilyn 

Horton, Designated Federal Official and 

Health Communication Specialist, Division 

of Health Assessment and Consultation, 

ATSDR, 1600 Clifton Road, NE., M/S E–32, 

Atlanta, Georgia 30333, telephone 1–888–42–

ATSDR (28737), fax (404) 498–1744. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and ATDSR. 

Dated: August 25, 2005. 

B. Kathy Skipper, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 05–17296 Filed 8–30–05; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

Educational Workshops on Current 

Good Manufacturing Practices; Public 

Workshops 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public workshops. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing a 

series of educational workshops on 

current good manufacturing practice 

(CGMP). The workshops, which will be 

held in collaboration with Peking 

University (Beijing, China) and the 

International Society for Pharmaceutical 

Engineering (ISPE), are intended to 

educate participants on current methods 

for compliance with good 

manufacturing practices (GMP). The 

workshops are being offered to help 

ensure effective CGMP programs and to 

further the common goals of FDA and 

providers of quality pharmaceutical 

products. 

DATES: See table 1 in the SUPPLEMENTARY

INFORMATION section of this document. 

ADDRESSES: See table 1 in the 

SUPPLEMENTARY INFORMATION section of 

this document. 

FOR FURTHER INFORMATION CONTACT: Erik 

N. Henrikson, Center for Drug 

Evaluation and Research (HFD–320), 

Food and Drug Administration, 11919 

Rockville Pike, Rockville, MD 20852,